Search results
Is the SPDR S&P 500 ETF Trust a Millionaire-Maker?
The Motley Fool via AOL· 1 hour agoWe all would love to wake up one day, check our brokerage accounts, and see the value of our investment top $1 million. The bad news is that this...
Good News for PayPal Stock Investors
Motley Fool via Yahoo Finance· 4 days agoNeil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some...
Apple's Big AI Reveal Underwhelms. Should You Buy the Stock Anyway?
Motley Fool via Yahoo Finance· 33 minutes agoOther capabilities were already available via third-party apps. Indeed, some observers noted that...
Here's Why Kinergy Advancement Berhad (KLSE:KAB) Has Caught The Eye Of Investors
Simply Wall St. via Yahoo Finance· 9 hours agoKinergy Advancement Berhad's Improving Profits Investors and investment funds chase profits, and...
IonQ Stock: Buy, Sell, or Hold?
The Motley Fool via AOL· 1 hour agoIonQ has many strengths and weaknesses as an investment opportunity. Let's assess the reasons to buy, sell, and hold the stock. Massive growth in 2024...
Should you invest in silver with gold's price high? Experts weigh in
CBS News· 20 hours agoGold investing surged in recent years. Thanks to inflation, geopolitical tensions, and the...
Nio Stock Could Still Double, According to 1 Wall Street Analyst
Motley Fool via Yahoo Finance· 2 days agoGood news for (new) Nio (NYSE: NIO) stock investors! Yesterday, Nio announced its first-quarter 2024...
2 Cryptocurrencies to Buy Whether Bitcoin Hits Another All-Time High or Not
Motley Fool via Yahoo Finance· 1 day agoSince these celebrities have millions of followers on social media, it's possible to argue that...
Is Now The Time To Look At Buying Novem Group S.A. (ETR:NVM)?
Simply Wall St. via Yahoo Finance· 4 days agoLet’s examine Novem Group’s valuation and outlook in more detail to determine if there’s still a...
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 18 hours agoThat is likely good news for Biogen and Eisai whose similar Alzheimer’s therapy will benefit from a...
